Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Squalamine

Generic Name: Squalamine

Drug Type: Small Molecule

Chemical Formula: C_₃₄H_₆₅N_₃O_₅S

CAS Number: 148717-90-2

Unique Ingredient Identifier: F8PO54Z4V7

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in ovarian cancer, lung cancer, and macular degeneration.

Associated Conditions

No associated conditions information available.

Clinical Trials

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

Phase 3

Posted: 2016/04/05

Sponsor:Ohr Pharmaceutical I...

ID:NCT02727881

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Phase 1

Completed

Posted: 2015/11/25

Sponsor:Ohr Pharmaceutical I...

ID:NCT02614937

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Phase 2

Withdrawn

Posted: 2015/07/30

Sponsor:Ohr Pharmaceutical I...

ID:NCT02511613

Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

Phase 2

Withdrawn

Posted: 2015/01/29

Sponsor:

Starr Muscle

ID:NCT02349516

Squalamine for the Treatment in Proliferative Diabetic Retinopathy

Phase 2

Completed

Posted: 2013/01/16

Sponsor:

Elman Retina Group

ID:NCT01769183

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy